Trial Profile
A phase Ib clinical safety trial in methamphetamine users
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 26 Apr 2016
Price :
$35
*
At a glance
- Drugs IXT-m200 (Primary)
- Indications Substance-related disorders
- Focus Adverse reactions
- 26 Apr 2016 New trial record